As Principal Research Scientist at Global Health Labs (GH Labs), Eric works to develop assays for detection of disease-causing bacteria and viruses based on RNA-programmable CRISPR Cas enzymes for use in low- and middle-income countries.

Prior to GH Labs, Eric was a Senior Research Scientist at Global Good, an investment fund of Intellectual Ventures. Previously he was a Visiting Assistant Professor at Wesleyan University, an Adjunct Lecturer at the University of New Haven, and an Adjunct Instructor at Merrimack College, focusing his teaching on Biochemistry and Molecular Biology. Prior to that he was a Scientist at US Genomics, where he developed single molecule methodologies for quantitative immunoassays and for investigating protein-ligand interactions.

As a post-doctorate fellow at the University of California-San Diego, the University of Colorado-Boulder and Genetics Institute, he investigated activation mechanisms of enzymes involved in mammalian signal transduction pathways using biochemical and biophysical approaches.

Eric earned his PhD in Cell and Developmental Biology from Harvard University and an AB in Biology from the University of Chicago.

‍